Javier Ripollés-Melchor1,2,3, Ane Abad-Motos4,5, Andrés Zorrilla-Vaca6,7. 1. Department of Anesthesiology, and Critical Care, Hospital Universitario Infanta Leonor, Gran Vía del Este 80, 2831, Madrid, Spain. ripo542@gmail.com. 2. Spanish Perioperative Audit and Research Network (ReDGERM), Zaragoza, Spain. ripo542@gmail.com. 3. Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care (SEDAR), Madrid, Spain. ripo542@gmail.com. 4. Department of Anesthesiology, and Critical Care, Hospital Universitario Infanta Leonor, Gran Vía del Este 80, 2831, Madrid, Spain. 5. Spanish Perioperative Audit and Research Network (ReDGERM), Zaragoza, Spain. 6. Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care (SEDAR), Madrid, Spain. 7. Department of Anesthesiology, Pain and Perioperative Medicine, Brigham and Women's Hospital, Boston, USA.
Abstract
PURPOSE OF THE REVIEW: The objective of this review is to address the rationale behind the application of the Enhanced Recovery After Surgery (ERAS) protocols that could improve oncologic outcomes in adult patients undergoing major surgery. RECENT FINDINGS: The implementation of ERAS protocols has been associated with fewer postoperative complications as well as decreased return to intended oncologic treatment (RIOT). However, few studies have analyzed the influence of the application of ERAS protocols and long-term oncologic outcomes, although some of its individual elements have been associated with improvements in oncologic outcomes, including overall survival and disease-free survival. Targeted long-term follow-up studies in specific oncologic procedures are required to determine whether ERAS application results in improved oncologic outcomes.
PURPOSE OF THE REVIEW: The objective of this review is to address the rationale behind the application of the Enhanced Recovery After Surgery (ERAS) protocols that could improve oncologic outcomes in adult patients undergoing major surgery. RECENT FINDINGS: The implementation of ERAS protocols has been associated with fewer postoperative complications as well as decreased return to intended oncologic treatment (RIOT). However, few studies have analyzed the influence of the application of ERAS protocols and long-term oncologic outcomes, although some of its individual elements have been associated with improvements in oncologic outcomes, including overall survival and disease-free survival. Targeted long-term follow-up studies in specific oncologic procedures are required to determine whether ERAS application results in improved oncologic outcomes.
Authors: Ester Miralpeix; Alpa M Nick; Larissa A Meyer; Juan Cata; Javier Lasala; Gabriel E Mena; Vijaya Gottumukkala; Maria Iniesta-Donate; Gloria Salvo; Pedro T Ramirez Journal: Gynecol Oncol Date: 2016-03-09 Impact factor: 5.482
Authors: S P Bisch; C A Jago; E Kalogera; H Ganshorn; L A Meyer; P T Ramirez; S C Dowdy; G Nelson Journal: Gynecol Oncol Date: 2020-12-30 Impact factor: 5.482
Authors: Jonathan G Hiller; Nicholas J Perry; George Poulogiannis; Bernhard Riedel; Erica K Sloan Journal: Nat Rev Clin Oncol Date: 2017-12-28 Impact factor: 66.675